Objectives: Central sensitization (CS) implies increased sensitivity of the nervous system, resulting in increased pain sensitivity as well as widespread pain. Recently, the Central Sensitization Inventory (CSI) was developed to assess symptoms of CS and central sensitivity syndromes. The aim of this study was to examine the convergent validity of the CSI by comparing the outcome to psychosocial factors and clinical features of CS. Methods: In a cross-sectional explorative study, patients with chronic pain completed multiple questionnaires, including the CSI, Pain Catastrophizing Scale, and Symptom Checklist 90, for psychological distress, duration of pain, intensity of pain, widespread pain, and lateralization of pain. Based on bivariate correlations, relevant predictors of CS were selected and used to fit an exploratory structural equation model (SEM) of CS. Results: In total, 114 patients with chronic pain were included, 56.1% being women. The average pain duration was 88 months. The mean total score on the CSI was 36.09 (15.26). The CSI was strongly related to known contributing and related factors of CS. SEM analysis showed that both psychological distress and widespread pain contributed 
INTRODUCTION
Pain research has changed the clinical view on pain, from a strict biomedical model towards the acceptance of a more bio-psycho-social understanding of pain. 1 Milestones in this new view were the gate control theory of Melzack and Wall, 2 followed by more recent findings indicating the involvement of central sensitization (CS) 3, 4 and neural plasticity. 2 These findings have led to a better understanding of the chronicity of pain syndromes, as well as a phenomenological difference between acute and chronic pain. 5 In the 20th century, several chronic pain syndromes were described based on perceived symptoms rather than sound etiology or pathogenesis. These syndromes have consequently been called somatically unexplained symptoms, or functional or functional somatic syndromes. Alternatively, Yunus proposed a list of 13 central sensitivity-related syndromes, including fibromyalgia, irritable bowel syndrome, whiplashassociated disorder, temporomandibular disorder, myofascial pain syndrome, and tension type headache, and proposed to label these as central sensitivity syndromes (CSSs). 6 Numerous studies confirmed that CS is (part of) the explanation for other well-known (subgroups of) chronic pain conditions such as low back pain (LBP), 7 osteoarthritis, 8 subacromial impingement syndrome, 9 and tendinopathy. 10 Central sensitivity, CS, and central mediated pain are all terms suggesting augmentation of responsiveness of central neurons to input of uni-and polimodal receptors, resulting in increased pain sensitivity as well as widespread pain and disproportional pain. 11 CS and somatosensory changes can be induced by bottom-up, nociceptive C-fiber input, and/or by top-down modulation. This top-down modulation may encompass malfunction of descending pain-inhibitory pathways or enhanced pain facilitation by psychosocial factors. Well-known psychosocial risk factors for CS and somatosensory changes are depression, fear, stress, and cognitive factors, including catastrophizing and inadequate illness perceptions. 12 In a worldwide survey of 17 countries investigating neck and back pain, mood and anxiety disorders were strongly related to chronic low back and neck pain. 13 Results from a meta-analysis of 41 studies indicate that anxiety sensitivity was strongly associated with fearful appraisals of pain and pain thresholds.
14 Neblett et al. 15 found associations between the outcome of the Central Sensitization Inventory (CSI), a questionnaire developed to assess symptoms of CS, and depressive symptoms, disability, sleep disturbance, and pain intensity. Since CSSs are common in health care, clinical tools that can aid in the diagnosis or recognition of predominant CS are needed. A first step is to determine the clinical features of predominant CS. Disproportional pain, an implausible neuroanatomical pain distribution, and sensory hypersensitivity were proposed as the main clinical features of predominant CS. 16 In addition, quantitative measures can also be found in the Quantitative Sensory Testing (QST) tools, which are used to demonstrate altered pain threshold, sensitivity, heat or cold, as well as allodynia and hyperalgesia. 17 These standardized tests are used with mechanical and thermal stimuli to characterize somatosensory profiles in patients. For daily clinical care, QST is time consuming, norm scores are not available, and the data from QST are difficult to interpret because sensory abnormalities are often bilateral, frustrating the left-right comparison. 18 Recently, Mayer et al. 19 developed a questionnaire attempting to measure signs of CS, the CSI. The original CSI contains 2 parts in which the first part (A) contains 25 items representing pain-related, psychosocial, cognitive, and functional items. The second part (B) contains 7 different CSSs, which are restless legs, chronic fatigue syndrome, fibromyalgia, temporomandibular joint disorder, migraine or tension headache, irritable bowel, and multiple chemical sensitivities, and 3 disorders relate to CSS, namely, neck pain (whiplash), depression, and anxiety or panic attacks. The questionnaire was tested in a group of patients with fibromyalgia (mean score on the CSI, M CSI = 58.2, SD = 10.5), chronic widespread pain (M CSI = 47.5, SD = 14.9), LBP (M CSI = 41.6, SD = 14.8), and a normative healthy control group (M CSI = 28.9, SD = 13.5). Significance differences were presented on the CSI total score among the groups. Furthermore a 4-factor structure was found, as were good test-retest reliability (r = 0.82), good internal consistency (Cronbach's a = 0.88), and promising construct validity based on comparisons of 3 subgroups of patients and a healthy control group. 19 The same group also described norm scores for the CSI 15,20 using a group of 121 patients from a multidisciplinary pain center, of whom 89 (74%) had 1 or more CSSs. A score of 40 in this study was found to best distinguish between control subjects and patients diagnosed with CSSs. Though one might assume that all of the patients with a CSS did indeed have some level of CS, no objective testing of CS was performed in this study. Compared to a nonpatient group, a score of 40 had an 81% sensitivity rate (true positive rate) and 75% specificity rate (true negative rate). 20 In a study using the CSI to identify chronic pain patients with, and without, an objective CSS diagnosis, the sensitivity was 82.8% and the specificity was 54.8%. 21 Similarly, the Dutch version of the CSI showed a 4-factor solution, good discriminative validity, and excellent test-retest reliability. 22 In this study, 368 patients with chronic pain from primary multidisciplinary and monodisciplinary physical therapy settings in Belgium and The Netherlands were included.
Although the CSI has been tested for several psychometric properties, the convergent validity of the questionnaire remains unknown. Since no gold standard is available for assessing CS, convergent validity should be evaluated by relating the CSI to the described clinical features of CS and psychosocial risk factors related to CS, such as catastrophizing, anxiety, and levels of psychological distress.
Taken together, there are 2 research questions to investigate the convergent validity of the CSI. First, is the CSI related to the contributing psychosocial factors for CS such as catastrophizing and psychological distress? Second, what is the relation between the CSI and clinical features of CS?
METHODS

Subjects
One hundred fourteen consecutive patients were included via referral to a transdisciplinary pain management center (Transcare, The Netherlands) by their medical specialist or general practitioner. This center works with transdisciplinary teams that include physicians, psychologists, and a physical therapist. The diagnosis for referral was chronic pain unresponsive to traditional medical treatment or other primary care treatments. The majority of patients were women (56.1%), and the age range was broad, with the youngest patient being 16 years old and the oldest patient in our sample being 88 years old (Table 1) .
Study Design and Setting
In this cross-sectional explorative study, all patients filled out a standardized list of questionnaires before admission to a transdisciplinary outpatient pain clinic. Sociodemographic data (gender, age) were collected as part of a standard diagnostic procedure. All patients filled out an informed consent for using these clinical data for scientific research. Since these measures were part of standard medical care, separate medical ethical approval was not needed.
The set of standard questionnaires was sent to the patients by regular mail. All patients filled out the questionnaire and returned it by regular mail with an included prepaid envelope. Patients filled out the questionnaires without supervision of a researcher in order to get valid and unbiased information. In case of missing data on 2 or fewer items of the total questionnaire, patients were asked to complete their questionnaires before the assessment in the presence of the researcher. Patients with missing data on more than 2 items were excluded from the study. Patients were included from January 2013 until June 2015. All questionnaires were imported using SPSS software (IBM Corp., Armonk, NY, U.S.A.) by one researcher.
Variables
All patients supplied sociodemographic information (gender, age) and responses to the following measures: a numbered visual analog scale (0 = no pain, 10 = worst pain; for their average pain over the preceding week), duration of pain in months, CSI-Dutch version, Pain Catastrophizing Scale (PCS), Symptom Checklist 90 (SCL-90), and the Widespread Pain Index (WPI). The translated CSI-Dutch version, described by Kregel et al. 22 , was filled out by all patients. The CSI consists of 2 parts. Part A contains 25 items presenting the pain-related psychosocial, cognitive, and functional items. Part B was not used in the present study.
The WPI was originally developed for patients with fibromyalgia and depicts 19 pain sites in an anatomical drawing. For this study we also included the head as one of the potential pain sites, leading to a maximum score of 20 pain sites. 23 Besides potential widespread pain, we also used the WPI data to create a binary variable named lateralization of pain to determine if the reported pain was 1-sided or 2-sided. The PCS is a self-reported questionnaire assessing pain catastrophizing. It is a 13-item scale in which patients are asked to reflect on past painful experiences and indicate the degree to which they experienced thoughts or feelings during pain on a 5-point scale. In the present study, the total score of the PCS was used. Total scores are counted by adding up all individual item scores. Higher scores correspond to more severe catastrophic thoughts about pain. The psychometric properties of the PCS are adequate. 24, 25 The SCL-90 is a multidimensional self-report inventory to assess current psychological symptoms. The SCL-90 yields 8 symptom domains, of which the dimensions phobic anxiety, anxiety, depression, somatization, insufficiency of thinking and acting, interpersonal sensitivity, hostility, and quality of sleep were assessed and used. Participants were asked to rate on a 5-point scale from 1 (not at all) to 5 (extreme) how much each item had distressed or bothered them during the past 7 days, including the day of the examination. The total score of this questionnaire can be calculated to result in a psychological distress score. The SCL-90 is used worldwide, and the psychometric properties have been considered adequate. 26 
Statistical Analysis
First, we calculated the means, standard deviations, and ranges of each demographic variable, pain-related measure, and questionnaire. The bivariate correlations between the total scores on the CSI, PCS, SCL-90, duration of pain complaints, intensity of pain experienced last week (VAS), WPI, lateralization of pain, and possible confounders age and gender were then analyzed using Pearson correlations. Spearman's rank correlations were used when 1 or more variables were skewed. Third, based on these correlations, we selected relevant predictors of patient-reported CS-related symptoms measured by the CSI and used these to fit a basic regression model followed by an explorative structural equation model (SEM) of CS. These path analyses contain 5 manifest predictor variables with 5 estimated standardized path coefficients in the basic regression analysis and 13 estimated standardized path coefficients in the explorative SEM. With our sample size of 114 subjects, we meet the criteria of an adequate sample size for the basic regression analysis. For the SEM we were a few participants short to meet those sample size criteria 27 ; however, this analysis is an exploratory one and performed to generate hypotheses instead of answering them. Furthermore, we would like to note that fitting data in a structural equation model does not prove the causal assumptions that we make, but it makes them tentatively more plausible.
28
The goodness-of-fit was evaluated with the following descriptive fit indices: (1) the Satorra-Bentler scaled v 2 global goodness of fit, which takes the non-normality into account; (2) the root mean square error of approximation (RMSEA); (3) the comparative fit index (CFI); and (4) the standardized root mean square residual (SRMR). The Satorra-Bentler scaled v 2 should yield P values of > 0.05, indicating a good fit. The RMSEA and SMRS should yield P values of < 0.06, indicating a good fit, 27 and P values of < 0.08 are indicative of an acceptable fit. 27 For the CFI, P > 0.95 indicates a good fit. 27 Bivariate correlations and standardized path coefficients are presented, and following Cohen, coefficients of 0.1 are small, 0.3 are moderate, and 0.5 are large in magnitude. 29 The STATA 14 statistical software package was used for all analyses. 30 An alpha of 0.05 was considered statistically significant.
RESULTS
The average pain duration was 88 months (range 3 to 480 months), and the mean (SD) pain intensity as measured by the VAS was 6.61 (1.73). Eighty-eight out of 114 patients (77.2%) reported bilateral pain. The mean (SD) total score on the CSI was 36.09 (15.26) (see Table 1 ).
The bivariate correlations are presented in Table 2 . It is notable that gender was not significantly correlated with any of the other variables. Age showed small to moderate correlations with duration of pain and the SCL-90 total score. The total score on the SCL-90, PCS, and WPI, as well as pain intensity experienced in the past week and lateralization of pain, all showed positive associations with the total score on the CSI.
Based on these correlations, we decided to use every variable that had a significant correlation with the CSI into the structural equation model, starting with a basic regression model where every variable had a direct causal relation with total score on the CSI. This model yielded only 2 significant relations, with a moderate effect found for WPI (b = 0.29, P < 0.001) and a large effect for the total score on the SCL-90 (b = 0.56, P < 0.001). This regression model was further used to explore if some of the variables that did not show a significant direct relation (PCS, lateralization of pain, and pain experienced in the past week) could influence CSI in an indirect way. The determination of the directions of the causal relations was based on current knowledge of existing literature. Lateralization of pain was not significantly associated with any of the other variables in the model and was dropped from the final model ( Figure 1 ).
The final model fit the data well (Satorra-Bentler scaled v 2 (4) = 2.76, P = 0.60; RMSEA and SMRS, both P < 0.05; CFI, P = 1.00). We found a strong association between the SCL-90 and the CSI (b = 0.57, P < 0.001).
The WPI had a moderately direct association with the CSI (b = 0.33, P < 0.001) and an indirect effect via the SCL-90. The PCS did not have a direct association with the CSI, but a significant indirect association via the SCL-90 was found. Finally, the pain VAS did not show a direct effect on the CSI, but an indirect effect through the PCS and SCL-90 was found.
DISCUSSION
In this study, we found an association between psychological distress and symptoms of CS using the CSI for patients with chronic pain. In relation to the convergent validity of the CSI, it was shown that the outcome of the CSI showed moderate to large associations with known contributing and related factors of CS. Likewise, it was found that both psychological distress, measured using the SCL-90, and widespread pain, measured with the WPI, contributed significantly to the variance in symptoms of CS in patients with chronic pain. In addition to psychological distress and widespread pain, it was found that pain catastrophizing did not contribute uniquely to the variance in symptoms of CS in patients with chronic pain. Standardized regression coefficients are presented. Dotted lines represent nonsignificant associations. *P < 0.05; **P < 0.01; ***P < 0.001.
We found a strong association of b = 0.57 for the CSI and the total score of the SCL-90, as well as a significant association of b = 0.33 for widespread pain. This relationship is consistent with previous research, where the relationship between chronic pain and psychological factors was emphasized.
15, [31] [32] [33] The relationship between CS and chronic widespread pain has also been emphasized before, mainly in central sensitivity-related syndromes. 16, 34, 35 In this explorative study of the CSI, we only used the total score of the SCL-90. This finding seems an argument to further explore the relationship of the CSI with specific domains of the SCL-90, such as depression, fear, somatization, and sleep. The size of our sample did not allow for examination of possible associations between symptoms of CS and specific SCL-90 domains; therefore, this is an important issue for further work in this area. Furthermore, future research should focus on possible relationships between the SCL-90 domains and the total score on the CSI, as well as the specific domains of the CSI described in the factor analyses by Mayer et al. and Kregel et al. 19, 22 The WPI showed a strong relation with the CSI outcome, as expected based on the algorithm by Nijs et al. 16 , in which diffuse or neuroanatomical illogical pain is proposed as a crucial sign of CS. This finding was also in agreement with the work done in a Delphi study on clinical indicators of nociceptive vs. neuropathic and CS pain, showing that "widespread, non-anatomical distribution of pain" obtained up to 96% consensus level agreement among expert clinicians as a clinical indicator of CS pain. 36 Similarly, in a study of 464 LBP patients, "non-segmental/diffuse areas of tenderness on palpation" was identified as 1 of the 4 key predictors of CS LBP vs. peripheral neuropathic and nociceptive LBP. 37 Looking at our data, the observed widespread pain seems to confirm a diffuse pain distribution, although exact definitions of both these features should be described more precisely. Catastrophizing did not show a direct significant relation in our model with the outcome of the CSI, although catastrophizing has been described as one of the modulating factors associated with alterations in supraspinal endogenous pain-inhibitory and -facilitatory processes, and therefore a factor in maintaining and or aggravating CS pain.
38, 39 Catastrophizing was originally used to describe a maladaptive cognitive strategy employed by patients with anxiety and depressive disorders. 40 In relation to pain, catastrophizing was characterized by the tendency to magnify the threat value of pain, ruminate about pain, and feel helpless in the context of pain, essentially an inability to inhibit pain-related thoughts in anticipation of, during, or following a painful encounter. 38 This study, however, showed that the association between catastrophizing and the CSI might be mediated by psychological distress.
No relationship was found between the CSI total scores and the duration of pain. A period of 3 to 6 months has been used for defining chronic pain. In our study, the average pain duration was 88 months (range 3 to 480 months). Future studies should also include pain patients with a pain duration of less than 1 year and examine whether pain duration is related to CS. No relationship was found between lateralization of pain and the CSI, although 77.2% of the patients showed pain on both sides. Perhaps this can be an important clinical feature, but in the same analyses with widespread pain, lateralization did not contribute significantly since a strong relationship between these 2 features was found.
For clinicians, this study examined the relationship between several clinical features of patients with longlasting pain and established contributing factors. In the past decade, several studies have used the mechanism of CS to explain long-lasting pain in patients in whom no somatic cause could be found. We are aware of the fact that more evidence is needed to understand these features before it is usable in clinical practice, but this study gives some first insight for implementation in further studies and clinical use. The psychometric properties found in former studies of the CSI establish the use of it as a tool for assessing symptoms related to CS and CSSs. 15, [19] [20] [21] The findings of convergent validity in this study also underline the use of the questionnaire in clinical practice. The study has several limitations and several strengths. All patients in the current study had long persisting pain, which means that the conclusion of this study cannot be generalized to all chronic pain patients, especially not the chronic pain patients with a shorter duration of pain. Furthermore, we included only patients referred to a pain management center, which might explain why the mean score on the CSI was lower compared to other studies describing the CSI. Second, while we used the SCL-90 total score, in future studies, the separate domains of the SCL 90 should be used to further explore if specific domains are related to symptoms of CS. The present study is cross-sectional in nature; therefore, the directions of the paths in the SEM model are based on theory and previous research. However, even though the good statistical fit of this proposed SEM model with the data does not prove the causal assumptions made, it does make them tentatively more plausible. Longitudinal studies would aid in developing more sound evidence for this theoretical model. Study strengths include the originality of the study: this is one of the first clinical studies exploring associations between several psycho-(patho)logical features of chronic pain and symptoms of CS. Therefore, the study will contribute to a better understanding of symptoms of CS in chronic pain patients seen in clinical practice. Finally, the use of validated measures and clear standardization of measures requires mentioning as study strengths.
